| # | % | |||||
|---|---|---|---|---|---|---|
| 451 | Nivalis Therapeutics Inc | 25,000 | 379,000 | 0.00% | ||
| 452 | MARRONE BIO INNOVATIONS INC | 184,037 | 364,000 | 0.00% | ||
| 453 | YRC WORLDWIDE INC COM PAR .01 | 27,695 | 359,000 | 0.00% | ||
| 454 | CYTOKINETICS INC | 50,607 | 340,000 | 0.00% | Call | |
| 455 | GEVO INC | 97,040 | 318,000 | 0.00% | Call | |
| 456 | GENOCEA BIOSCIENCES INC | 22,398 | 308,000 | 0.00% | ||
| 457 | CYTOKINETICS INC | 40,485 | 272,000 | 0.00% | ||
| 458 | AETNA INC NEW | 2,022 | 258,000 | 0.00% | ||
| 459 | GLYCOMIMETICS INC | 31,830 | 253,000 | 0.00% | ||
| 460 | CYNAPSUS THERAPEUTICS INC | 15,000 | 244,000 | 0.00% | ||
| 461 | EXA CORP | 18,300 | 204,000 | 0.00% | ||
| 462 | TETRALOGIC PHARMA CO | 83,786 | 196,000 | 0.00% | ||
| 463 | INVUITY INC | 12,351 | 174,000 | 0.00% | ||
| 464 | APIGEE CORP | 15,247 | 151,000 | 0.00% | ||
| 465 | ALLIQUA BIOMEDICAL INC | 25,478 | 134,000 | 0.00% | ||
| 466 | ACHAOGEN INC COM | 14,188 | 86,000 | 0.00% | ||
| 467 | RLJ ENTMT INC | 200,000 | 79,000 | 0.00% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001164691-15-000132, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
